Replimune Group, Inc.
REPL
$8.03
$0.050.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 60.09% | 70.22% | 54.05% | 22.04% | 9.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.56% | 38.62% | 24.90% | 11.60% | 5.42% |
| Operating Income | -35.56% | -38.62% | -24.90% | -11.60% | -5.42% |
| Income Before Tax | -38.44% | -45.71% | -27.27% | -14.60% | -8.86% |
| Income Tax Expenses | -181.96% | 14.71% | 126.09% | 14.71% | -32.98% |
| Earnings from Continuing Operations | -37.95% | -45.65% | -27.37% | -14.60% | -8.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.95% | -45.65% | -27.37% | -14.60% | -8.71% |
| EBIT | -35.56% | -38.62% | -24.90% | -11.60% | -5.42% |
| EBITDA | -36.69% | -38.79% | -24.42% | -10.68% | -3.37% |
| EPS Basic | -11.46% | -13.28% | 1.51% | 5.21% | 2.49% |
| Normalized Basic EPS | -11.82% | -13.33% | 1.59% | 5.22% | 2.33% |
| EPS Diluted | -11.46% | -13.28% | 1.51% | 5.21% | 2.49% |
| Normalized Diluted EPS | -11.82% | -13.33% | 1.59% | 5.22% | 2.33% |
| Average Basic Shares Outstanding | 23.39% | 27.71% | 28.44% | 20.66% | 11.85% |
| Average Diluted Shares Outstanding | 23.39% | 27.71% | 28.44% | 20.66% | 11.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |